Ray Dalio Zoetis Inc. Transaction History
Bridgewater Associates, LP
- $17.3 Billion
- Q3 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Zoetis Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 51,789 shares of ZTS stock, worth $9.16 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
51,789
Previous 82,715
37.39%
Holding current value
$9.16 Million
Previous $14.3 Million
29.44%
% of portfolio
0.06%
Previous 0.08%
Shares
15 transactions
Others Institutions Holding ZTS
# of Institutions
1,957Shares Held
412MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.29 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.51 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.5 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.84 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.72 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $82.8B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...